What You’re Missing Matters: How Oxford Nanopore sequencing can power deeper discovery with greater efficiency

Genomics is paving the way for personalised medicine, allowing healthcare providers to tailor interventions based on an individual’s genetic makeup, which can lead to more effective treatments and improved outcomes.

Clinical research in South Africa increasingly incorporates genomic data to better understand conditions prevalent in the region, such as HIV, cancer, and rare genetic diseases. This approach not only helps identify novel risk factors and therapeutic targets, but also ensures that healthcare strategies are more relevant and accessible to the diverse local population. As genomic databases grow and become more representative, the potential for early diagnosis, preventative care, and precision medicine expands, ultimately enhancing public health and reducing disparities.

Despite these promising developments, challenges such as resource limitations and the need for greater inclusion in global genomic studies remain. Continued investment in genomics research and capacity building will be essential to fully realise the benefits for South Africa’s population, fostering a future where healthcare is more equitable, predictive, and personalised.

Power deeper discovery with greater efficiency. Oxford Nanopore sequencing delivers rich, comprehensive data for even the most complex clinical questions.

Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.

Please note that this is an in-person event.

There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com

More details to follow.